Business Case Studies, Organizational Behavior Case Study, Strategy, Growth Strategies Case Studies

print page
Tell A Friend
Bookmark

Growth Strategies Case Study

IBS CDC IBS CDC IBS CDC IBS CDC RSS Feed
Case Title:

AstraZeneca's Growth Strategies

Publication Year : 2005

Authors: Abdul Samad, Sumit Kumar Chaudhuri

Industry: Pharmaceuticals Manufacturers

Region: UK

Case Code: GRS0130

Teaching Note: Available

Structured Assignment: Not Available


OR





Abstract:
Formed on April 6 th 1999 through the merger of Zeneca Group Plc. from the UK, and Astra AB from Sweden, AstraZeneca is engaged in research, development, manufacturing and marketing of prescription pharmaceuticals and health care services. By 2005, it was among the top five pharmaceutical companies in the world with a turnover of US$21.4 billion.

Pedagogical Objectives:

  • To highlight the rationale behind the formation of AstraZeneca
  • To discuss AstraZeneca's growth strategy of focusing on the research and development of innovative drugs to fulfil global health care needs.

Keywords : Biggest pharmaceutical companies; ICI; Global investments in pharmaceutical research and development; Novartis; Clinical research; Restructuring at AstraZeneca; Balanced Scorecard (BSC); Growth Strategies Case Study; Over the counter drugs; Health care services; GlaxoSmithKline; Agrochemicals; Speciality drugs; Prescription pharmaceuticals; Oncology; Neuroscience

Contents : 
Coming Out from the Shadows of ICI
Growth Strategies
Future Plans
Innovative Products from ICI
The ICI Group
AstraZeneca’s Product Portfolio
AstraZeneca’s Product Pipeline

Contact us: IBS Case Development Centre (IBSCDC), IFHE Campus, Donthanapally, Sankarapally Road, Hyderabad-501203, Telangana, INDIA.
Mob: +91- 9640901313,
E-mail: casehelpdesk@ibsindia.org

©2020-2025 IBS Case Development Centre. All rights reserved. | Careers | Privacy Policy | Terms of Use | Disclosure | Site Map xml sitemap